EP1189632A4 - Pneumococcal surface protein combination vaccine - Google Patents

Pneumococcal surface protein combination vaccine

Info

Publication number
EP1189632A4
EP1189632A4 EP00947640A EP00947640A EP1189632A4 EP 1189632 A4 EP1189632 A4 EP 1189632A4 EP 00947640 A EP00947640 A EP 00947640A EP 00947640 A EP00947640 A EP 00947640A EP 1189632 A4 EP1189632 A4 EP 1189632A4
Authority
EP
European Patent Office
Prior art keywords
surface protein
combination vaccine
protein combination
pneumococcal surface
pneumococcal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00947640A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1189632A1 (en
Inventor
Robert C Huebner
Jacquelyn S Sampson
George M Carlone
Edwin Ades
David E Briles
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur SA
UAB Research Foundation
Centers of Disease Control and Prevention CDC
Original Assignee
Aventis Pasteur SA
UAB Research Foundation
Centers of Disease Control and Prevention CDC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pasteur SA, UAB Research Foundation, Centers of Disease Control and Prevention CDC filed Critical Aventis Pasteur SA
Publication of EP1189632A1 publication Critical patent/EP1189632A1/en
Publication of EP1189632A4 publication Critical patent/EP1189632A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP00947640A 1999-06-10 2000-06-09 Pneumococcal surface protein combination vaccine Withdrawn EP1189632A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US13842299P 1999-06-10 1999-06-10
US138422P 1999-06-10
US58783300A 2000-06-06 2000-06-06
US587833 2000-06-06
PCT/US2000/040176 WO2000076541A1 (en) 1999-06-10 2000-06-09 Pneumococcal surface protein combination vaccine

Publications (2)

Publication Number Publication Date
EP1189632A1 EP1189632A1 (en) 2002-03-27
EP1189632A4 true EP1189632A4 (en) 2002-08-21

Family

ID=26836182

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00947640A Withdrawn EP1189632A4 (en) 1999-06-10 2000-06-09 Pneumococcal surface protein combination vaccine

Country Status (7)

Country Link
EP (1) EP1189632A4 (cg-RX-API-DMAC7.html)
JP (1) JP2003519089A (cg-RX-API-DMAC7.html)
AU (1) AU6121000A (cg-RX-API-DMAC7.html)
BR (1) BR0011478A (cg-RX-API-DMAC7.html)
CA (1) CA2379327A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA01012721A (cg-RX-API-DMAC7.html)
WO (1) WO2000076541A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7078042B2 (en) * 1995-09-15 2006-07-18 Uab Research Foundation Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
US20010016200A1 (en) 1998-04-23 2001-08-23 Briles David E. Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
GB0022742D0 (en) * 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
EP1477802A1 (en) * 2003-05-16 2004-11-17 Erasmus Universiteit Rotterdam Method for selecting and producing vaccine components and vaccines based thereon
JP2010501012A (ja) * 2006-08-17 2010-01-14 ザ ユーエービー リサーチ ファウンデーション 免疫原性ＰｃｐＡポリペプチドおよびその使用
RU2510281C2 (ru) * 2012-06-22 2014-03-27 Общество с ограниченной ответственностью "Эпитоп" (ООО "Эпитоп") ВАКЦИНА ПРОТИВ ПНЕВМОНИИ, ВЫЗЫВАЕМОЙ Streptococcus pneumoniae, НА ОСНОВЕ ГИБРИДНОГО БЕЛКА
GB201318170D0 (en) * 2013-10-14 2013-11-27 Univ Edinburgh Proteins with Diagnostic and Therapeutic Uses
KR101627285B1 (ko) * 2014-06-05 2016-06-07 한국생명공학연구원 ＰｓｐＡ를 유효성분으로 포함하는 퇴행성 뇌질환의 예방 또는 치료용 약학 조성물

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994014318A1 (en) * 1992-12-24 1994-07-07 Medimmune, Inc. Method of protection against streptococcus pneumoniae with transformed mycobacteria
WO1999053940A1 (en) * 1998-04-23 1999-10-28 Uab Research Foundation PNEUMOCOCCAL SURFACE PROTEIN C(PspC), EPITOPIC REGIONS AND STRAIN SELECTION THEREOF, AND USES THEREFOR

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854416A (en) * 1991-11-14 1998-12-29 The United States Of America As Represented By The Department Of Health And Human Services Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor
CA2326408A1 (en) * 1998-03-02 1999-09-10 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Epitope peptides immunogenic against streptococcus pneumoniae

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994014318A1 (en) * 1992-12-24 1994-07-07 Medimmune, Inc. Method of protection against streptococcus pneumoniae with transformed mycobacteria
WO1999053940A1 (en) * 1998-04-23 1999-10-28 Uab Research Foundation PNEUMOCOCCAL SURFACE PROTEIN C(PspC), EPITOPIC REGIONS AND STRAIN SELECTION THEREOF, AND USES THEREFOR

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
BRILES D E ET AL: "Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA).", CLINICAL MICROBIOLOGY REVIEWS. UNITED STATES OCT 1998, vol. 11, no. 4, October 1998 (1998-10-01), pages 645 - 657, XP000946754, ISSN: 0893-8512 *
BRILES D E ET AL: "PSPA AND PSPC: THEIR POTENTIAL FOR USE AS PNEUMOCOCCAL VACCINES", MICROBIAL DRUG RESISTANCE, LIEBERT, US, vol. 3, no. 4, 1997, pages 401 - 408, XP000946756, ISSN: 1076-6294 *
BRILES D E ET AL: "PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 14, no. 9, 1 June 1996 (1996-06-01), pages 858 - 867, XP004057611, ISSN: 0264-410X *
BRILES D E ET AL: "The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 19, 8 December 2000 (2000-12-08), pages S87 - S95, XP004227955, ISSN: 0264-410X *
BROOKS-WALTER A ET AL: "The pspC gene encodes a second pneumococcal surface protein homologous to the gene encoding the protection-eliciting PspA protein of Streptococcus pneumoniae.", ABSTRACTS OF THE GENERAL MEETING OF THE AMERICAN SOCIETY FOR, vol. 97, 1997, 97th General Meeting of the American Society for Microbiology;Miami Beach, Florida, USA; May 4-8, 1997, 1997, pages 35, XP001083844, ISSN: 1060-2011 *
MCDANIEL L S ET AL: "IMMUNIZATION WITH A PLASMID EXPRESSING PNEUMOCOCCAL SURFACE PROTEIN A (PSPA) CAN ELICIT PROTECTION AGAINST FATAL INFECTION WITH STREPTOCOCCUS PNEUMONIAE", GENE THERAPY, MACMILLAN PRESS LTD., BASINGSTOKE, GB, no. 4, April 1997 (1997-04-01), pages 375 - 377, XP001068798, ISSN: 0969-7128 *
SAMPSON ET AL: "Limited Diversity of Streptococcus pneumoniae psaA among Pneumococcal Vaccine Serotypes", INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY. WASHINGTON, US, vol. 65, no. 5, May 1997 (1997-05-01), pages 1967 - 1971, XP002108304, ISSN: 0019-9567 *
SAMPSON J S ET AL: "CLONING AND NUCLEOTIDE SEQUENCE ANALYSIS OF PSAA, THE STREPTOCOCCUSPNEUMONIAE GENE ENCODING A 37-KILODALTON PROTEIN HOMOLOGOUS TO PREVIOUSLY REPORTED STREPTOCOCCUS S. ADHESINS", INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY. WASHINGTON, US, vol. 62, no. 1, 1994, pages 319 - 324, XP000749404, ISSN: 0019-9567 *
See also references of WO0076541A1 *
THARPE ET AL: "Purification and seroreactivity of pneumococcal surface adhesin A (PsaA)", CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 3, no. 2, March 1996 (1996-03-01), pages 227 - 229, XP002109329, ISSN: 1071-412X *

Also Published As

Publication number Publication date
WO2000076541A1 (en) 2000-12-21
BR0011478A (pt) 2002-03-19
AU6121000A (en) 2001-01-02
MXPA01012721A (es) 2004-10-14
EP1189632A1 (en) 2002-03-27
JP2003519089A (ja) 2003-06-17
CA2379327A1 (en) 2000-12-21

Similar Documents

Publication Publication Date Title
NO20031483D0 (no) Vaksine
NO20014322D0 (no) Vaksine
NO20024172L (no) Vaksine
DK1210113T3 (da) Kombinerede vaccinepræparater
CY2011008I1 (el) Εμβολιο γριπης
DK1023904T3 (da) Adjuvanser til anvendelse i vacciner
DK1292612T3 (da) Glycopeptidphosphonatderivater
DZ3399A1 (fr) Composition de vaccin polyvalent
DZ3219A1 (fr) Vaccin
ATE490327T1 (de) Impfstoffzusammensetzung
DZ2462A1 (fr) Vaccin antigrippal.
DK1326638T3 (da) Vacciner mod cancer
DE60002650D1 (de) Öladjuvierter Impfstoff
EP1278044A4 (en) Angular sensor
DK1265633T3 (da) Vaccineadjuvans
EP1423141A4 (en) VACCINE
EP1189632A4 (en) Pneumococcal surface protein combination vaccine
DE60222900D1 (de) Uv-abschirmende peptid-flavonoid konjugate
ATE519775T1 (de) Rekombinante untereinheiten-impfstoffe
ATE293126T1 (de) Cyclische hexapeptidderivate
FI991553L (fi) Imulaite
DK1180041T4 (da) Vaccine mod ISA-virus
SE0001833D0 (sv) Peptidkonjugat
NO20002213D0 (no) Babesia vaksine
DK1259535T3 (da) Cykliske hexapeptidderivater

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020104

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20020705

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 39/09 A

17Q First examination report despatched

Effective date: 20031229

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040709